Literature DB >> 2539252

Promotion of cystine uptake, increase of glutathione biosynthesis, and modulation of glutathione status by S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR-2721) in Chinese hamster cells.

R D Issels1, A Nagele.   

Abstract

We recently found that exposure of cells to different aminothiols promotes cystine uptake and leads to an increase of cellular glutathione by new biosynthesis (Issels et al., Biochem. Pharmacol., 37: 881-888, 1988). Therefore, we further investigated whether the known radioprotective and chemoprotective aminothiol derivative S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721) or its dephosphorylated form (WR-1065) will lead to similar effects. In order to convert WR-2721 to the free thiol compound (WR-1065) in vitro, the medium also contained 20 U/ml alkaline phosphatase (AP). For uptake studies a modified McCoy's 5A medium supplemented with 0.1 mM [35S]cystine was used. In Chinese hamster ovary (CHO) and Chinese hamster ovarian carcinoma (OvCa) cells, WR-2721 exposure alone did not increase the cystine uptake relative to that of control (untreated) cells, while WR-2721 + AP enhanced the uptake of cystine more than twofold in both cell lines. The increase of cystine uptake was dependent on the time of exposure (0-60 min) and the concentrations of WR-2721 (0-8 mM) + AP. Half-maximal uptake of cystine was observed at concentrations of 0.69 and 0.57 mM WR-2721 in CHO and OvCa cells, respectively. Determination of both reduced (GSH) and oxidized (GSSG) cellular glutathione levels after the exposure (0-300 min) to WR-2721 + AP in CHO cells showed a depletion of GSH to less than 10% of the pretreatment value and a 4-fold reduction of the GSH/GSSG ratio. In contrast, in OvCa cells the amount of total glutathione rather increased with no significant change of the GSH/GSSG ratio by the exposure to WR-2721 + AP. Further analysis using high-performance liquid chromatography of cell extracts revealed that the relative amount of incorporated [35S]-cystine into glutathione was increased similarly in both cell lines. The data show that precursor availability and new biosynthesis of glutathione is enhanced by the exposure to WR-2721 + AP in vitro despite the differential modulation of the cellular glutathione status in the two cell lines. These findings may have important implications for the use of aminothiols like WR-2721 in various cells and tissues in regard of their response to chemotherapeutic agents, ionizing radiation and/or hyperthermia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539252

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Amino acids and their derivatives as radioprotective agents.

Authors:  J C Roberts
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

2.  Mechanism for the changes in levels of glutathione upon exposure of cultured mammalian cells to tertiary-butylhydroperoxide and diamide.

Authors:  T Ochi
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

Review 3.  Amifostine: potential for clinically useful cytoprotection.

Authors:  G T Budd; V Lorenzi; R Ganapathi; D Adelstein; R Pelley; T Olencki; D McLain; R M Bukowski
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

4.  Effects of thiols on topoisomerase-II alpha activity and cell cycle progression.

Authors:  D J Grdina; J S Murley; J C Roberts
Journal:  Cell Prolif       Date:  1998 Oct-Dec       Impact factor: 6.831

5.  Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma.

Authors:  Trevor McKibbin; John C Panetta; Maryam Fouladi; Amar Gajjar; Feng Bai; M Fatih Okcu; Clinton F Stewart
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

6.  In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue.

Authors:  L Pierelli; G Scambia; A Fattorossi; G Bonanno; A Battaglia; A Perillo; G Menichella; P B Panici; G Leone; S Mancuso
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.